Abstract Background: Colorectal carcinogenesis has been found to be associated with the polymorphic status of Toll-like receptor 4 gene in various populations of the world.
Introduction
Colorectal cancer (CRC) is one of the commonly diagnosed cancers in both men and women. It ranks third most common cancer in men and second most in women worldwide [1] . The incidence of this malignancy shows considerable variation among racially or ethnically defined populations in multiracial/ethnic countries. Kashmir (Indian Administered) has been reported as a high-incidence area of gastrointestinal cancers (GIT) [1] [2] [3] . In Kashmir valley CRC represents the third most common GIT cancer [3, 4] after esophageal and gastric cancers; and among males CRC ranks as fourth common cancer and third among females [2, 3] .
Toll-like receptors (TLRs) play a vital role in immune responses, being involved in the regulation of inflammatory reactions and activation of the adaptive immune response to eliminate infectious pathogens and cancer debris [5] [6] [7] .
The TLR4 gene is mapped on chromosome 9 and consists of three exons. Two common non-synonymous SNPs (+896A/G rs4986790 and +1196C/T rs4986791) have been found in exon 3 of gene which induce substitution of amino acids Asp299Gly and Thr399Ile, respectively. The substitution of Asp299Gly disrupts the normal structure of the extracellular region of the TLR4, which may cause decreased ligand recognition or protein interaction and decreased responsiveness to lipopolysaccharide [8] . Consequently, such change can affect the transport of TLR4 to the cell membrane and lead to an exaggerated inflammatory response with severe tissue destruction [9] . TLR4 Asp299Gly and Thr399Ile are known to co-segregate in 10% of the Caucasian populations and are reported to have positive correlation with susceptibility to several diseases. However, neither SNP is present in Asian populations [10] .
CRC is one of the few cancers in which inflammation is the basic pathological incident which later on can transform into full blown malignancy [11] [12] [13] [14] . Furthermore, a positive association between various innate immune system mediators and bacterial toxins with the development of CRC has also been found [15] ; together with the fact that TLRs serve as the mediators of inflammation in the gut and are known to be crucial regulators in maintaining the balance between commensal bacteria in the gut and the mucosal immune system [16, 17] .
In addition, the potential association between TLR4 genetic polymorphisms and the risk of bladder cancer, prostate cancer, breast cancer, melanoma [18] [19] [20] [21] , hepatocellular carcinoma [22] , gastric cancer [23] [24] [25] and gastric mucosa associated lymphoid tissue lymphoma has been proposed [26] . Both TLR4 polymorphisms are also involved in advancement of Head and neck squamous cell carcinoma (HNSCC) and may serve as biomarkers for HNSCC [27] . In fact, some studies have reported a significant role of TLR4 polymorphisms in increasing the risk of colorectal cancer as well in their respective populations [28, 29] .
Therefore, the potential role of the TLR4 polymorphisms in the development and progression of CRC becomes much more important to be researched upon, provided the limited data are available on colorectal cancer.
In the present study, we conducted a case-control study to find out the relevance of TLR4 polymorphisms (Asp299Gly and Thr399Ile) in colorectal cancer patients of Kashmiri population. Furthermore we also investigated whether there is a link between the clinic-pathological variables and the TLR4 Asp299Gly and/or Thr399Ilegenotypes and hence their role in modulating the risk of colorectal cancer.
Subjects and methods

Subjects
This study included 120 consecutive primary CRC patients recruited from Department of Surgery, Sher-I-Kashmir Institute of Medical Science, Kashmir, India. Tumor types and stages were determined by two experienced pathologists. The cases who had not received any chemo or radiotherapy were chosen for this study. Blood samples of 200 age and sex matched individuals with no signs of any malignancy were collected for controls. The mean age of both patient and control groups was 55 years.
Data on all CRC patients were obtained from personal interviews with patients and or guardians (for those who were illiterate), medical records and pathology reports. The data collected included sex, age, dwelling, tumor location, Dukes Stage, lymph node status. All patients and or guardians were informed about the study and their will to participate in this study was taken on predesigned questionnaire (Available on request). The collection and use of tumor and blood samples for this study were previously approved by the appropriate Institutional Ethics Committee. The work has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments in humans.
DNA extraction & genotype analysis
DNA extraction was performed using Ammonium Acetate Method. One lL (50 ng) of DNA was used as the template for each PCR cycle.
Analysis of TLR-4 Asp299Gly and Thr399Ile Polymorphisms Genotyping was performed using PCR-RFLP method as described previously [30] . Primers (Genescript, USA, New Jersey) for TLR4 Asp299Gly were forward (F5 0 GATTAGCA TACTTAGACTACTACCTCCATG) and reverse (R5 0 GAT-CAACTTC TGA AAAAGCATTCCCAC) and Nco-I enzyme (Fermentas, USA, Maryland) was used for digestion. Similarly, primers for TLR4 Thr399Ile were forward (F5 0 GGTTGC TGTTCTCAAAGTGATTTTGGGAGAA) and reverse (R5 0 CCTGAAGACTGGAGAGTGAGTTAAATGCT) and Hinf-I (Fermentas) was used to carry out restriction digestion.
Briefly PCR was carried out in a final volume of 25 lL containing 50 ng genomic DNA templaten, 1Â PCR buffer with 2 mM MgCl 2 , 0.5 lM of each primer (Genescript), 50 lM dNTPs (Fermentas) and 0.5 U DNA polymerase (Fermentas). For PCR amplification, the standard program was used as follows: one initial denaturation step at 94°C for 7 min, followed by 35 denaturation cycles of 30 sat 95°C, 30 s of annealing at 55°C, and 30 s of extension at 72°C, followed by a final elongation cycle at 72°C for 7 min.
PCR product of 249 bp and 406 bp for TLR4 Asp299Gly and Thr399Ile respectively were resolved for confirmation of PCR through a 2-3 per cent agarose gel (Genie, India, Bangalore). Both amplicons were then restriction digested at 37°C for genotypic of two SNPs.
For, TLR4 Asp299Gly 249 bp was identified as homozygous wild type AA, while three bands of 249 bp, 226 bp and 23 bp were identified as heterozygous variant allele AG and the homozygous mutant type GG displayed two bands of 226 bp and 23 bp. For, TLR4 Thr399Ile 406 bp was identified as wild type CC, while three bands of 406 bp, 377 bp and 29 bp were identified as heterozygous variant allele CT and the homozygous mutant type TT displayed two bands of 377 bp and 29 bp. The genotypes of >20 per cent of the samples were reassessed in a double-blind manner by two independent researchers, to confirm the results. A positive control for each polymorphism was used for 50 per cent of the samples.
Statistical analysis
The observed frequencies of the above genotypes in patients with CRC were compared with the controls using chi-square or fisher exact tests when the expected frequencies were small. The chi-square test was used to verify whether the genotype distributions were in Hardy-Weinberg equilibrium (for allele and genotype frequencies in our population). Statistical significance was set at p < 0.05.Statistical analyses were performed using PASW version 18 software.
Results
A total of 120 cases and 200 control subjects were included in this study with prior consent. Out of 120 confirmed cases of CRC, 72 were males and 48 cases were females; 66 were rural 54 were urban; 52 cases had carcinoma in colon and 68 in rectum; 59 were smokers and 61 non-smokers. The mean age of patients having confirmed CRC was 55 years. Among control subjects, 149 consisted of males and 51 females. No significant gender-or age-related differences were observed between the groups (p > 0.05).
Among 120 CRC cases, we found the frequency of heterozygous state of TLR-4 Asp299Gly polymorphism to be 10.8% (13/120) while the frequency in the general control population was 15.4% (31/200) . Likewise the frequency of heterozygous state of TLR-4 Thr399Ile polymorphism was found to be 15% (18/120) in cases and 9% (18/200) among controls. Variant homozygous genotype was not found in both the polymorphisms in either the cases or the controls. The overall association between the TLR4 polymorphism and the CRC cases was found to be insignificant (p > 0.05) ( Table 1) . However CT genotype showed a modest elevated risk of the development of CRC [OR = 1.78 95% CI (0.88-3.5)]. Furthermore, analysis of the gene interactions of the two SNPs of TLR4 gene also did not reveal any significant association between the genotypes (p > 0.05) ( Table 2) .
We also analyzed the correlation of TLR-4 Asp299Gly polymorphism with the clinicopathological characteristics and found the G allele carrier to be significantly associated with the males (p value = 0.006) and involvement of lymph nodes (p value = 0.01) ( Table 3 ). The Thr399Ile polymorphism study showed the T allele carrier to be significantly associated with the smokers (p value = 0.03) ( Table 4 ).
Discussion
Toll-like receptors (TLRs) belong to Type I Transmembrane Glycoproteins, Containing three important domains: (a) the 608 residue ecto-domain -found outside the cell or in cytoplasm and contains multiple leucine-rich repeats (LRR) participating in the recognition and binding of pathogens, (b) single trans membrane domain (STM), (c) 187 residue toll/interleukin 1 receptor (TIR) domain. LRRs harbor 24-29 residues that fold into parallel b-sheets [8, 10, 31] .
It has been found by various studies that the lowfunctioning TLR4 polymorphisms usually result in reduced inflammatory response correlating with the low-damaging infection but a persistent infection [32] [33] [34] . Genetic variants of TLR4 polymorphisms Asp299Gly and Thr399Ile have been found to disrupt the structure of the extracellular region of TLR4 protein. This in turn leads to the disturbance of normal TLR signaling creating a pro-inflammatory environment that favors tumor growth and chemo resistance and hence plays a pivotal role in carcinogenesis process [35] , or immunosuppression induced by chronic inflammation [7, 36, 37] .
TLR4 Asp299Gly gene variant has an impact on TLR4 signaling and potentially on intestinal homeostasis due to impaired control signals at the epithelial cell level leading to chronic intestinal inflammation & interrupted intestinal homeostasis and hence may lead to CRC [38] .
In this study we evaluated the distribution of TLR4 Asp299Gly and TLR4 Thr399Ile polymorphisms in CRC patients and controls, but we didn't find a significant statistical difference in the distribution among the two groups. Comparing all CRC patients to healthy controls, the adjusted OR for CRC risk was 1.5 (95% CI, 0.75-3.01) and 0.56 (95% CI, 0.27-1.12) for Asp299Gly and Thr399, respectively. We also did not find any homozygous variant genotype among any of the cases or controls of the study. The results are consistent with the already published studies [10] .
Although none of the two polymorphisms was found to be significantly associated with CRC statistically, however G allele (AG genotype) of TLR-4 Asp299Gly polymorphism was found to be significantly associated with the male gender (p value = 0.006) and involvement of Nodes (p value = 0.01) ( Table 3) and T allele (CT genotype) of Thr399Ile polymorphism showed significant association with the smoking status (p value = 0.03).
A recent meta-analysis by Sheng et al. [39] found that the GG genotype carriers of TLR4 gene had higher risk of developing CRC than AA + GA genotype carriers (p = 0.05). Furthermore, stratified analyses showed that the genetic models of the Asian group had higher risk of developing CRC than the Caucasian group. They concluded that the GG genotype of TLR4 Asp299Gly and the TT genotype of TLR4 Thr399Ile polymorphisms might be correlated with an increased risk of CRC, indicating that they may serve as biomarkers of disease progression Another meta-analysis by Li et al. [40] found an empirical evidence of involvement of TLR4 gene in driving CRC and this TLR4 may serve as a potential biomarker for the early diagnosis of CRC. Zhang et al., [41] in their meta-analysis for TLR4 gene polymorphisms found both TLR4 (299/399) polymorphisms to be associated with increased cancer risk and one SNP (rs1927911) with decreased cancer risk.
Third meta-analysis by Jing et al. [7] has shown TLR4 polymorphisms to be positively associated with the increased risk of digestive tract cancers. Their results suggested that Asp299Gly has a risk effect on gastrointestinal cancers but it tends to be a protective factor on prostate cancer. They also reported significant geographic and ethnic differences in the intercontinental incidence of Asp299Gly and Thr399Ile polymorphisms with both SNPs found to be present in 10% of Caucasian populations. Zou et al. [42] also reported similar results in their meta-analysis of TLR4 gene polymorphisms and concluded that the association between TLR4 Thr399Ile polymorphism and cancer risk was significant in both South Asians and East Asians, but not in Caucasians.
Omrane et al. [28] found a strong association between both of the TLR4 polymorphisms and CRC. They reported a significant association of TL4 polymorphisms with numerous clinicpathological parameters (tumor differentiation (p = 0.027) and tumor architecture (p = 0.02), advanced stage (p = 0.03) and concluded that TLR4 polymorphisms may serve as potential biomarker of CRC progression. Pimentel-Nunes et al. [29] in their study on European CRC patients reported that the functional polymorphisms in TLR2 and TLR4 significantly alter the risk of developing CRC. Furthermore they also reported that the risk of cancer gets exemplified in the overweight individuals.
However, there are a number of studies on various populations which have observed a non-association of TLR4 gene polymorphisms with the risk of modulating CRC [43, 44] . A number of studies have shown overexpression of TLR4 to be associated with the metastatic colorectal cancer [45] [46] [47] ; while as a few have shown that loss of expression or strong downregulation of TLR4 is associated with the metastatic colorectal cancer [48] , while some reported no change in expression by variant status of TLR4 [11] .
Furthermore, a number of studies reported from India on various cancers have implicated TLR4 polymorphism in modulating the risk of cancers [49] [50] [51] [52] . So, our study is also an extension of such efforts to elucidate the role played by various genetic polymorphisms in modulating the risk of CRC.
Conclusion
In conclusion, our results suggest that TLR4 gene polymorphism is not a key modulator of the risk of developing colorectal cancer in Kashmiri population.
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